What's Going On With Bright Minds Biosciences Stock Friday?

Bright Minds Biosciences Inc. (NASDAQ:DRUG) shares are moving higher on Friday. The company announced a $35 million non-brokered private placement.

The Details: Each share in the private placement is priced at $21.70, while pre-funded warrants are available at a price of $21.69 each. Pre-funded warrants can be converted into stock at the time the investor chooses or within five years from the closing date.

The company plans to use the gross proceeds from this private placement for general working capital as well as research and development in connection to its drug development programs.

Bright Minds stock is up more than 100%, trading on higher-than-normal volume Friday. The stock has an average session volume over the past 100 days of 2.22 million, but is currently trading on a session volume of 10.62 million.

How To Buy Bright Minds Biosciences Stock

By now you're likely curious about how to participate in the market for Bright Minds Biosciences – be it to purchase shares, or even attempt to bet against the company.

Related Link: MicroStrategy Boss Michael Saylor Taunts Bitcoin Doubters, Challenges Them To Short Company’s Stock: ‘I Want You To Love Us If You Really Hate BTC’

DRUG Price Action: As of Friday morning, Bright Minds stock is trading 153.5% higher at $55.01, according to data from Benzinga Pro.

Image: Image: Akava Photo from Pixabay

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.